SCHEMBL23864786

SCHEMBL23864786

BC1(N2C(=O)c3cccc(N)c3C2(B)B)CCC(=O)NC1=O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 5/20 0.39
▸ DDB1 Q16531 4/20 0.39
▸ TNF P01375 2/20 0.39
▸ IL1B P01584 2/20 0.39
▸ IKZF1 Q13422 2/20 0.39
▸ IKZF3 Q9UKT9 2/20 0.39
▸ TBXA2R P21731 1/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ CYP19A1 P11511 9/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP17A1 P05093 1/20 0.35
▸ CYP11A1 P05108 1/20 0.35
▸ TBXAS1 P24557 1/20 0.35
▸ PMP22 Q01453 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281328 0.81 CYP19A1 (0.35) CRBNDDB1CYP19A1CYP3A4CYP17A1
SCHEMBL20459229 0.75 CRBN (0.43) CRBNDDB1TNFIL1BIKZF1
SCHEMBL23979831 0.73 CRBN (0.46) CRBNDDB1TNFIL1BIKZF1
SCHEMBL23979970 0.73 CRBN (0.46) CRBNDDB1TNFIL1BIKZF1
SCHEMBL23979944 0.73 CRBN (0.46) CRBNDDB1TNFIL1BIKZF1
SCHEMBL23979453 0.70 CRBN (0.47) CRBNDDB1TNFIL1BIKZF1
SCHEMBL23979978 0.70 CRBN (0.47) CRBNDDB1TNFIL1BIKZF1
SCHEMBL23979565 0.70 CRBN (0.47) CRBNDDB1TNFIL1BIKZF1
SCHEMBL5958850 0.69 CRBN (0.50) CRBNDDB1TNFIL1BIKZF1
SCHEMBL19310143 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3581182-B1 COMBINATION TREATING PROSTATE CANCER, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD KANGPU BIOPHARMACEUTICALS LTD (CN) 2021-09-29 — — EP disclosed
Send feedback